These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 28246150)

  • 1. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry.
    Maione L; Brue T; Beckers A; Delemer B; Petrossians P; Borson-Chazot F; Chabre O; François P; Bertherat J; Cortet-Rudelli C; Chanson P;
    Eur J Endocrinol; 2017 May; 176(5):645-655. PubMed ID: 28246150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National acromegaly registries.
    Maione L; Chanson P
    Best Pract Res Clin Endocrinol Metab; 2019 Apr; 33(2):101264. PubMed ID: 30894298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update.
    Gadelha MR; Kasuki L; Lim DST; Fleseriu M
    Endocr Rev; 2019 Feb; 40(1):268-332. PubMed ID: 30184064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
    Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic.
    Mercado M; Gonzalez B; Vargas G; Ramirez C; de los Monteros AL; Sosa E; Jervis P; Roldan P; Mendoza V; López-Félix B; Guinto G
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4438-46. PubMed ID: 25210882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypertension and acromegaly in the elderly: French Registry Data].
    Dupuy O; Petrossian T; Bordier L; Mayaudon H; Bauduceau B;
    Arch Mal Coeur Vaiss; 2007 Aug; 100(8):660-3. PubMed ID: 17928771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.
    Fieffe S; Morange I; Petrossians P; Chanson P; Rohmer V; Cortet C; Borson-Chazot F; Brue T; Delemer B;
    Eur J Endocrinol; 2011 Jun; 164(6):877-84. PubMed ID: 21464140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.
    Reid TJ; Jin Z; Shen W; Reyes-Vidal CM; Fernandez JC; Bruce JN; Kostadinov J; Post KD; Freda PU
    Pituitary; 2015 Dec; 18(6):808-19. PubMed ID: 25907335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.
    Salvatori R; Gordon MB; Woodmansee WW; Ioachimescu AG; Carver DW; Mirakhur B; Cox D; Molitch ME
    Pituitary; 2017 Dec; 20(6):605-618. PubMed ID: 28741071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects.
    Bex M; Abs R; T'Sjoen G; Mockel J; Velkeniers B; Muermans K; Maiter D
    Eur J Endocrinol; 2007 Oct; 157(4):399-409. PubMed ID: 17893253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
    Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
    J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy).
    Colao A; Vandeva S; Pivonello R; Grasso LF; Nachev E; Auriemma RS; Kalinov K; Zacharieva S
    Eur J Endocrinol; 2014 Aug; 171(2):263-73. PubMed ID: 24878680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.
    Yaron M; Izkhakov E; Sack J; Azzam I; Osher E; Tordjman K; Stern N; Greenman Y
    Pituitary; 2016 Jun; 19(3):322-31. PubMed ID: 26873588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
    Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to achieve disease control in acromegaly: cause analysis by a registry-based survey.
    Schöfl C; Grussendorf M; Honegger J; Tönjes A; Thyroke-Gronostay D; Mayr B; Schopohl J;
    Eur J Endocrinol; 2015 Apr; 172(4):351-6. PubMed ID: 25599707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of Diabetes and Hypertension After Multimodal Treatment of Acromegaly.
    González B; Vargas G; de Los Monteros ALE; Mendoza V; Mercado M
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2369-2375. PubMed ID: 29618021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic and clinical burden of comorbidities among patients with acromegaly.
    Whittington MD; Munoz KA; Whalen JD; Ribeiro-Oliveira A; Campbell JD
    Growth Horm IGF Res; 2021 Aug; 59():101389. PubMed ID: 34126556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis.
    Placzek H; Xu Y; Mu Y; Begelman SM; Fisher M
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1106-12. PubMed ID: 26679960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.
    Petroff D; Tönjes A; Grussendorf M; Droste M; Dimopoulou C; Stalla G; Jaursch-Hancke C; Mai M; Schopohl J; Schöfl C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3894-902. PubMed ID: 26244491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.